Author

Helen F. Barker

Observed names: H. BARKER, H. Barker, H. F. Barker, H.F. Barker, Helen Barker, Helen F. Barker

Observed institutions: Heidelberg University, Queen Elizabeth Hospital Birmingham, Birmingham City Hospital, Royal Hallamshire Hospital, Northern General Hospital, Rotherham General Hospital, The Rotherham NHS Foundation Trust, Wessex Regional Genetics Laboratory, University of Southampton, Medizinische Fakultät Mannheim, University of Birmingham

OpenAlex ID: A5047822695

The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2

2005 · Andreas Reiter, Christoph Walz, et al. · Cancer Research · 269

Clinical experience with Zarzio® in Europe: what have we learned?

2013 · Pere Gascón, Hans Tesch, et al. · Supportive Care in Cancer · 100

Posttransplant immune‐mediated hemolysis

2002 · Robert J. Sokol, Robert Stamps, et al. · Transfusion · 83

Expression of adhesion molecules LFA‐3 and N‐CAM on normal and malignant human plasma cells

1992 · H. F. Barker, M. S. Hamilton, et al. · British Journal of Haematology · 74

The determination of a reference range for new platelet parameters produced by the Bayer ADVIATM 120 full blood count analyser

2000 · D.R. Brummitt, H.F. Barker · Clinical & Laboratory Haematology · 70

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

2024 · Nigel H. Russell, Charlotte Wilhelm-Benartzi, et al. · Journal of Clinical Oncology · 57

The Role of Adhesion Molecules in Multiple Myeloma

1992 · Helen F. Barker, Jennifer Ball, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 22

D-Dimer Assay for Deep Vein Thrombosis: its Role with Colour Doppler Sonography

2000 · M. BRADLEY, J. BLADON, et al. · Clinical Radiology · 18

Very late antigen (VLA) expression by normal and neoplastic human plasma cells; including an assessment of antibodies submitted to the Vth International Workshop on Leucocyte Differentiation Antigens using human myeloma cell lines

1996 · Marion Drew, Helen F. Barker, et al. · Leukemia Research · 18

A new platelet parameter, the mean platelet component, can demonstrate abnormal platelet function and structure in myelodysplasia

2003 · D.R. Brummitt, H.F. Barker, et al. · Clinical & Laboratory Haematology · 16

Clonal stability in late‐relapsing childhood lymphoblastic leukaemia

1997 · Lindsay Frost, Anne Goodeve, et al. · British Journal of Haematology · 14

Multiple myeloma: The biology of malignant plasma cells

1993 · H.F. Barker, J. Ball, et al. · Blood Reviews · 10

May–Hegglin anomaly: the role of aspirin in the treatment of this rare platelet disorder in pregnancy

2002 · Abdalla M. Fayyad, David R. Brummitt, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 7

Mitoxantrone, Etoposide and Prednisolone—a Novel Combination in The Treatment of Relapsed and Refractory Lymphoma

1990 · H. F. Barker, R. M. I. Jan-mohamed, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 3

Use of Biosimilar G-CSF for Prevention of Chemotherapy-Induced Neutropenia: Pooled Analysis of Clinical Usage Studies

2012 · P. Gascon, H. Tesch, et al. · Annals of Oncology

Recurrent Fusion of PCM1 to JAK2 in Atypical Chronic Myeloid Leukemia and Acute Leukemia Associated with the t(8;9)(p21-22;p23-24).

2004 · Andreas Reiter, Christoph Walz, et al. · Blood

Works count: 16

Citation count: 761

H-index: 11

I10-index: 12